Last reviewed · How we verify
pyrrobutamine
pyrrobutamine is a drug. It is currently in unknown development.
Pyrrobutamine is an antihistamine and anticholinergic. It is used to treat conditions such as allergic reactions and possibly other conditions as indicated by ClinicalTrials.gov.
At a glance
| Generic name | pyrrobutamine |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pyrrobutamine CI brief — competitive landscape report
- pyrrobutamine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about pyrrobutamine
What is pyrrobutamine?
pyrrobutamine is a pharmaceutical drug.
What development phase is pyrrobutamine in?
pyrrobutamine is in unknown.
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing